We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 48.96%
This Fund
S&P 500
This Quarter Est. Return
-15.1%
1 Year Est. Return
+48.96%
3 Year Est. Return
+156.47%
5 Year Est. Return
+196.14%
10 Year Est. Return
+689.54%
AUM
$1.29B
AUM Growth
-$350M
Cap. Flow
-$26.9M
Cap. Flow %
-2.09%
Top 10 Hldgs %
26.92%
Holding
2,725
New
403
Increased
995
Reduced
859
Closed
275

Sector Composition

Rank Sector Weight
1 Technology 19.38%
2 Healthcare 15.01%
3 Financials 10.3%
4 Consumer Discretionary 8.01%
5 Communication Services 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLY icon
1801
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
$5K ﹤0.01%
94
-106
-53% -$6.26K
TECX
1802
Tectonic Therapeutic
TECX
$622M
$5K ﹤0.01%
28
-167
-86% -$39.3K
EVBN
1803
DELISTED
Evans Bancorp Inc
EVBN
$5K ﹤0.01%
+218
New +$7.7K
INFN
1804
DELISTED
Infinera Corporation Common Stock
INFN
$5K ﹤0.01%
+986
New +$6.76K
LSXMA
1805
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$5K ﹤0.01%
+230
New +$7.27K
MORF
1806
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5K ﹤0.01%
399
-999
-71% -$16.7K
CBAY
1807
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
3,519
+2,150
+157% +$3.61K
CURO
1808
DELISTED
CURO Group Holdings Corp.
CURO
$5K ﹤0.01%
919
-12,193
-93% -$116K
LBC
1809
DELISTED
Luther Burbank Corporation Common Stock
LBC
$5K ﹤0.01%
531
PRTK
1810
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5K ﹤0.01%
1,685
+991
+143% +$3.66K
AMRS
1811
DELISTED
Amyris Inc.
AMRS
$5K ﹤0.01%
+2,092
New +$6.11K
APTX
1812
DELISTED
Aptinyx Inc. Common Stock
APTX
$5K ﹤0.01%
2,191
-2,334
-52% -$7.64K
JNCE
1813
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$5K ﹤0.01%
956
-11,194
-92% -$64.4K
CHRA
1814
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$5K ﹤0.01%
260
+130
+100% +$3.02K
OTIC
1815
DELISTED
Otonomy, Inc.
OTIC
$5K ﹤0.01%
2,774
-3,354
-55% -$10.3K
AFI
1816
DELISTED
Armstrong Flooring, Inc.
AFI
$5K ﹤0.01%
3,221
+522
+19% +$1.62K
ADMS
1817
DELISTED
Adamas Pharmaceuticals
ADMS
$5K ﹤0.01%
+1,763
New +$7.9K
WRI
1818
DELISTED
Weingarten Realty Investors
WRI
$5K ﹤0.01%
+354
New +$9.34K
TNAV
1819
DELISTED
Telenav Inc.
TNAV
$5K ﹤0.01%
+1,274
New +$6.56K
STML
1820
DELISTED
Stemline Therapeutics, Inc.
STML
$5K ﹤0.01%
+1,120
New +$7.26K
I
1821
DELISTED
INTELSAT S. A.
I
$5K ﹤0.01%
3,124
+2,130
+214% +$8.92K
UFS
1822
DELISTED
DOMTAR CORPORATION (New)
UFS
$5K ﹤0.01%
225
-1,619
-88% -$51.5K
STL
1823
DELISTED
Sterling Bancorp
STL
$5K ﹤0.01%
438
+212
+94% +$3.66K
ADNT icon
1824
Adient
ADNT
$1.45B
$4K ﹤0.01%
401
-20
-5% -$403
AMPH icon
1825
Amphastar Pharmaceuticals
AMPH
$902M
$4K ﹤0.01%
269
-546
-67% -$9.5K

Similar funds

Meeder Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Meeder Asset Management held 2,725 positions worth $1.29B, down 21% from $1.64B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Meeder Asset Management's Q1 2020 filing shows 403 new, 995 increased, 859 reduced and 275 closed positions. Its largest new stake was Chimera Investment: 33,620 shares worth $916K. The largest sale was Xtrackers USD High Yield Corporate Bond ETF, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Meeder Asset Management's largest Q1 2020 buy was Chimera Investment: 33,620 shares worth $916K.
  • Meeder Asset Management added most to Vanguard Short-Term Bond ETF in Q1 2020, an estimated $32.1M increase.
  • Meeder Asset Management's biggest Q1 2020 reduction was Xtrackers USD High Yield Corporate Bond ETF, cutting an estimated $23.8M.
  • Meeder Asset Management fully exited Dolby in Q1 2020, selling an estimated $775K.
  • Meeder Asset Management's ten largest holdings make up 27% of its $1.29B portfolio in Q1 2020.
  • Meeder Asset Management opened 403 new positions and closed 275 in Q1 2020.
  • Meeder Asset Management's portfolio value fell 21% quarter-over-quarter to $1.29B.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.